Middle East & Africa Embolotherapy Market Forecast to 2028

Report Code : BMIRE00027548 | Region : LAMEA | Industry : Medical Device | Published Date : 23/Nov/2022
Middle East & Africa Embolotherapy Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Embolic Agent and Support Device), Disease Indication (Cancer, Peripheral Vascular Disease, Neurological Disease, Urological and Nephrological Disorder, Gastrointestinal Disorder, and Other), Procedure [Transcatheter Arterial Embolization (TAE), Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT), and Transarterial Chemoembolization (TACE)], and End User (Hospital & Clinic, Ambulatory Surgery Center, and Other End User)

The embolotherapy market in the Middle East & Africa is expected to grow from US$ 183.66 million in 2022 to US$ 261.89 million by 2028. It is estimated to grow at a CAGR of 6.1% from 2022 to 2028.

Widening Applications of Embolotherapy to Bolster Embolotherapy Market in Middle East & Africa during 2022–2028

Embolization is performed within the artery (endovascular) through a steerable catheter inserted into the bloodstream and guided to the brain. Further, post-traumatic bleeding embolization is performed to stop bleeding caused by traumatic injuries. The method uses materials to block the affected vessel and stops blood flow. According to a Netcare hospital article, traumatic brain injury (TBI) is one of the leading causes of disability in South Africa, and 89,000 new cases of TBI are reported every year in the country. Thus, the rising adoption of embolization in various applications further increases the demand for embolization agents and supportive devices. Therefore, the growing applications of embolotherapy devices are expected to boost the growth of the embolotherapy market. Also, the increasing implementation of embolotherapy in the treatment of endovascular disease, traumatic injuries, cerebrovascular malformation, venous malformation, arteriovenous malformation, and pediatric vascular conditions is expected to offer lucrative opportunities for the market growth in the coming years.

Market Overview

The embolotherapy market in the Middle East & Africa is segmented into Saudi Arabia, the UAE, South Africa, and the rest of Middle East & Africa. In the current market scenario, Middle East is experiencing an increasing incidence of chronic diseases, such as strokes, neurological disorders, and cancer; rise in geriatric population; and adaption of unhealthy lifestyles. Moreover, acceptance and installations of modern technologies are projected to drive the market growth in this region. The high incidence of chronic diseases, the rise in aging population, and improvements in the treatment procedures of various chronic conditions are among the key factors propelling the market growth in Saudi Arabia. CVD is the most significant cause of premature death in Saudi Arabia. It accounts for ~37% of deaths in the country. As per a study, the prevalence rates of chronic diseases in Saudi Arabia has surged in the past few years, accounting for ~60 and ~73% of the total premature deaths in 2016 and 2020, respectively. Hypertension is the most common chronic disease, with prevalence rates of 26%. In addition, in the country, the incidence of uterine fibroids (UFs) at reproductive age is 21.2% in 2018 and poses a major burden on fertile Saudi women. Uterine fibroid embolization, a safe, effective, and minimally invasive procedure is becoming an important gynecological and interventional radiological procedure to treat UF. King Fahd Hospital – Al-Hofouf has successfully treated several benign uterine fibroids cases using uterine fibroid embolization, as per Al-Ahsa Health Affairs. This treatment uses a form of real-time x-ray to guide delivery of embolic agents to the uterus and fibroids. The agents block the arteries that provide blood to the fibroids and cause them to shrink and clear up.

Middle East & Africa Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Embolotherapy Market Segmentation

The Middle East & Africa embolotherapy market is segmented into product, disease indication, procedure, end user, and country.

Based on procedure, the market is segmented into embolic agents and support devices. The embolic agents segment registered the largest market share in 2022. Based on disease indication, the market is categorized into cancer, neurological diseases, urological and nephrological disorders, peripheral vascular diseases, gastrointestinal disorders, and others. The cancer segment held the largest market share in 2022. Based on procedure, the Middle East & Africa embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization/selective internal radiation therapy, and transarterial chemoembolization (TACE). The transcatheter arterial embolization (TAE) segment held the largest market share in 2022. Based on end user, the Middle East & Africa embolotherapy market is segmented into hospitals and clinics, ambulatory surgical centers, and other end users. The hospitals and clinics segment held the largest market share in 2022. Based on country, the market is segmented into Saudi Arabia, South Africa, the UAE, and the rest of the MEA. China dominated the market share in 2022. Abbott Laboratories; Boston Scientific Corporation; Cook Medical LLC; Johnson & Johnson; Medtronic; Acandis GmbH; Balt USA LLC; Stryker Corporation; Guerbet LLC; and Terumo Corporation are the leading companies operating in the embolotherapy market in the region.

The List of Companies - Middle East & Africa Embolotherapy Market

● Abbott Laboratories

● Boston Scientific Corporation

● Cook Medical LLC        

● Johnson & Johnson

● Medtronic

● Acandis GmbH  

● Balt USA LLC

● Stryker Corporation

● Guerbet LLC

● Terumo Corporation

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Middle East & Africa Embolotherapy Market – by Product

1.3.2 Middle East & Africa Embolotherapy Market – by Disease Indication

1.3.3 Middle East & Africa Embolotherapy Market – by Procedure

1.3.4 Middle East & Africa Embolotherapy Market – by End User

1.3.5 Middle East & Africa Embolotherapy Market– By Country

2. Middle East & Africa Embolotherapy Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Middle East & Africa Embolotherapy Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Expert Opinion

5. Middle East & Africa Embolotherapy Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Boosting Incidence of Cancer Cases

5.1.2 Surging Incidence of Hypertension, Obesity, Smoking, and Alcoholism

5.2 Market Restraints

5.2.1 Presence of Other Alternative Therapies

5.3 Market Opportunity

5.3.1 Widening Applications of Embolotherapy

5.4 Market Trend

5.4.1 Higher Use of Liquid Embolic Agents

5.5 Impact analysis

6. Middle East & Africa Embolotherapy Market Analysis

6.1 Middle East & Africa Embolotherapy Market Revenue Forecast and Analysis

7. Middle East & Africa Embolotherapy Market – by Product

7.1 Overview

7.2 Middle East & Africa Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)

7.3 Embolic Agents

7.3.1 Overview

7.3.2 Embolic Agents: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.3 Microspheres

7.3.3.1 Overview

7.3.3.2 Microspheres: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.4 Embolic Coils

7.3.4.1 Overview

7.3.4.2 Embolic Coils: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.5 Embolic Plug Systems

7.3.5.1 Overview

7.3.5.2 Embolic Plug Systems: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.6 Detachable Balloons

7.3.6.1 Overview

7.3.6.2 Detachable Balloons: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.7 Liquid Embolic Agents

7.3.7.1 Overview

7.3.7.2 Liquid Embolic: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.3.8 Others

7.3.8.1 Overview

7.3.8.2 Others: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4 Support Devices

7.4.1 Overview

7.4.2 Support Devices: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4.3 Microcatheters

7.4.3.1 Overview

7.4.3.2 Microcatheters: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

7.4.4 Guidewires

7.4.4.1 Overview

7.4.4.2 Guidewires: Embolotherapy Market– Revenue and Forecast to 2028 (US$ Million)

8. Middle East & Africa Embolotherapy Market Analysis – by Disease Indication

8.1 Overview

8.2 Middle East & Africa Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)

8.3 Cancer

8.3.1 Overview

8.3.2 Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.1 Liver Cancer

8.3.2.1.1 Overview

8.3.2.1.2 Liver Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.2 Kidney Cancer

8.3.2.2.1 Overview

8.3.2.2.2 Kidney Cancer: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.3.2.3 Other Cancers

8.3.2.3.1 Overview

8.3.2.3.2 Other Cancers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Peripheral Vascular Diseases

8.4.1 Overview

8.4.2 Peripheral Vascular Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Neurological Diseases

8.5.1 Overview

8.5.2 Neurological Diseases: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Urological and Nephrological Disorders

8.6.1 Overview

8.6.2 Urological and Nephrological Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Gastrointestinal Disorders

8.7.1 Overview

8.7.2 Gastrointestinal Disorders: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

8.8 Others

8.8.1 Overview

8.8.2 Others: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East & Africa Embolotherapy Market Analysis – by Procedure

9.1 Overview

9.2 Middle East & Africa Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)

9.3 Transcatheter Arterial Embolization (TAE)

9.3.1 Overview

9.3.2 Transcatheter Arterial Embolization (TAE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.4 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)

9.4.1 Overview

9.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

9.5 Transarterial Chemoembolization (TACE)

9.5.1 Overview

9.5.2 Transarterial Chemoembolization (TACE): Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10. Middle East & Africa Embolotherapy Market Analysis – By End User

10.1 Overview

10.2 Middle East & Africa Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)

10.3 Hospitals and Clinics

10.3.1 Overview

10.3.2 Hospitals: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.4 Ambulatory Surgical Centers

10.4.1 Overview

10.4.2 Ambulatory Surgical Centers: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

10.5 Other End Users

10.5.1 Overview

10.5.2 Other End Users: Embolotherapy Market – Revenue and Forecast to 2028 (US$ Million)

11. Middle East & Africa Embolotherapy Market – Country Analysis

11.1 Overview

11.1.1 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, By Country (%)

11.1.1.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.1 Overview

11.1.1.1.2 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.1.3 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

11.1.1.1.3.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

11.1.1.1.3.2 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

11.1.1.1.4 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

11.1.1.1.4.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

11.1.1.1.5 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

11.1.1.1.6 Saudi Arabia: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

11.1.1.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.1 Overview

11.1.1.2.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.2.3 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

11.1.1.2.3.1 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

11.1.1.2.3.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

11.1.1.2.4 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

11.1.1.2.4.1 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

11.1.1.2.5 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

11.1.1.2.6 South Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

11.1.1.3 UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.1 Overview

11.1.1.3.2 UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.3.3 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

11.1.1.3.3.1 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

11.1.1.3.3.2 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

11.1.1.3.4 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

11.1.1.3.4.1 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

11.1.1.3.5 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

11.1.1.3.6 UAE: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

11.1.1.4 Rest of Middle East and Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.1 Overview

11.1.1.4.2 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)

11.1.1.4.3 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

11.1.1.4.3.1 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

11.1.1.4.3.2 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

11.1.1.4.4 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

11.1.1.4.4.1 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

11.1.1.4.5 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

11.1.1.4.6 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

12. Middle East & Africa Embolotherapy Market –Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Abbott Laboratories

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 Boston Scientific Corporation

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Cook Medical LLC

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Johnson & Johnson

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Medtronic

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Acandis GmbH

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 Balt USA LLC

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 Stryker Corporation

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

13.9 Guerbet LLC

13.9.1 Key Facts

13.9.2 Business Description

13.9.3 Products and Services

13.9.4 Financial Overview

13.9.5 SWOT Analysis

13.9.6 Key Developments

13.10 Terumo Corporation

13.10.1 Key Facts

13.10.2 Business Description

13.10.3 Products and Services

13.10.4 Financial Overview

13.10.5 SWOT Analysis

13.10.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES.

Table 1. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

Table 2. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

Table 3. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

Table 4. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

Table 5. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

Table 6. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

Table 7. Saudi Arabia: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 8. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

Table 9. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

Table 10. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

Table 11. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

Table 12. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

Table 13. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

Table 14. South Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 15. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

Table 16. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

Table 17. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

Table 18. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

Table 19. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

Table 20. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

Table 21. UAE: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 22. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)

Table 23. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)

Table 24. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)

Table 25. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)

Table 26. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)

Table 27. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)

Table 28. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)

Table 29. Organic Developments Done by Companies

Table 30. Inorganic Developments Done by Companies

Table 31. Glossary of Terms, Middle East & Africa Embolotherapy Market

The List of Companies - Middle East & Africa Embolotherapy Market

● Abbott Laboratories

● Boston Scientific Corporation

● Cook Medical LLC        

● Johnson & Johnson

● Medtronic

● Acandis GmbH  

● Balt USA LLC

● Stryker Corporation

● Guerbet LLC

● Terumo Corporation

Reason To Buy

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Middle East & Africa embolotherapy market.

● Highlights key business priorities in order to assist companies to realign their business strategies

● The key findings and recommendations highlight crucial progressive industry trends in the Middle East & Africa embolotherapy market, thereby allowing players across the value chain to develop effective long-term strategies

● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets

● Scrutinize in-depth Middle East & Africa market trends and outlook coupled with the factors driving the embolotherapy market, as well as those hindering it

● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

AVAILABLE CUSTOMIZATION RESEARCH METHODOLOGY REQUEST FOR TOC FREE SAMPLE REPORT
CHOOSE LICENCE TYPE
(Middle East & Africa Embolotherapy Market Forecast to 2028)
  • Single User Price $3,000$2,400
  • Site Price $4,000$3,200
  • Enterprise Price $5,000$4,000
Buy Now Add to Cart
REQUEST FOR TOC
SPEAK TO ANALYST
FREE SAMPLE
REPORT
INQUIRE BEFORE
BUYING
TOP
Quick Enquiry